We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$146M
1-Year Est. Return
25.93%
This Fund
S&P 500
This Quarter
Est. Return
+10.61%
1 Year Est. Return
+25.93%
3 Year Est. Return
+30.87%
5 Year Est. Return
+45.28%
10 Year Est. Return
+379.83%
AUM
$914M
AUM Growth
+$105M
(+13%)
Cap. Flow
-$40M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
58.3%
Holding
41
New
10
Increased
8
Reduced
13
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mercury Systems
MRCY
|
+$31.9M |
| 2 |
Humana
HUM
|
+$30.9M |
| 3 |
SharkNinja
SN
|
+$26.4M |
| 4 |
Sprinklr
CXM
|
+$25.7M |
| 5 |
Corteva
CTVA
|
+$24.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Indivior Pharmaceuticals
INDV
|
+$42M |
| 2 |
Norfolk Southern
NSC
|
+$38.8M |
| 3 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$25.7M |
| 4 |
Qorvo
QRVO
|
+$20.2M |
| 5 |
Harmonic Inc
HLIT
|
+$17.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 26.1% |
| 2 | Healthcare | 22.11% |
| 3 | Technology | 18.87% |
| 4 | Consumer Discretionary | 13.33% |
| 5 | Materials | 4.92% |
Similar funds
AWM
SIM
TA
2L
AFM
ECM
CWM
CCM
Scopia Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Scopia Capital Management held 41 positions worth $914M, up 13% from $809M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Scopia Capital Management withdrew a net $40M in Q1 2024, closing 9 positions and reducing 13 holdings. Its most notable exit was Norfolk Southern, an estimated $38.8M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 32% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Scopia Capital Management opened a new position in Mercury Systems worth $31.2M.
- Scopia Capital Management's largest Q1 2024 buy was Mercury Systems: 1,059,172 shares worth $31.2M.
- Scopia Capital Management added most to Marqeta in Q1 2024, an estimated $10.3M increase.
- Scopia Capital Management's biggest Q1 2024 reduction was Indivior Pharmaceuticals, cutting an estimated $42M.
- Scopia Capital Management fully exited Norfolk Southern in Q1 2024, selling an estimated $38.8M.
- Scopia Capital Management's ten largest holdings make up 58% of its $914M portfolio in Q1 2024.
- Scopia Capital Management opened 10 new positions and closed 9 in Q1 2024.
- Scopia Capital Management's portfolio value rose 13% quarter-over-quarter to $914M.
Based on Scopia Capital Management's 13F filing for Q1 2024, filed 15 May 2024.